Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2021 Filed Aug 4, 2021 21:02 UTC |
Hall Charles JGroup President
|
SaleCommon Stock | 3,000 | $251.94 | $755,820.00 |
DisclosureSEC source: 0001209191-21-049817 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,870 Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 19:17 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionStock Appreciation Right · Derivative | 37,500 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-21-050053 · doc4.xml · derivative · entry 8 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 19:17 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Tax withholdingCommon Stock | 18,093 | $253.51 | $4,586,756.43 |
DisclosureSEC source: 0001209191-21-050053 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,788 Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 19:17 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Exercise / conversionCommon Stock | 37,500 | $37.18 | $1,394,250.00 |
DisclosureSEC source: 0001209191-21-050053 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 19:16 UTC |
Cuffe Michael S.President-Physician Services
|
SaleCommon Stock | 2,500 | $251.91 | $629,774.50 |
DisclosureSEC source: 0001209191-21-050052 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · President-Physician Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,914.3007 F1 · balance_after: Includes 2,154.3007 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 19:26 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 409 | $249.57 | $102,073.31 |
DisclosureSEC source: 0001209191-21-049480 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,018 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.50 to $249.68, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
SaleCommon Stock | 8,631 | $250.00 | $2,157,750.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 20 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By DJP 2020 Trust Disclosed balance after: 44,348 Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
SaleCommon Stock | 100 | $250.07 | $25,006.50 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 19 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By JBP 2020 Trust Disclosed balance after: 34,729 Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
SaleCommon Stock | 11,269 | $250.00 | $2,817,250.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 18 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By JBP 2020 Trust Disclosed balance after: 34,829 Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
SaleCommon Stock | 20,000 | $250.00 | $5,000,000.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 17 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2021 Trust Disclosed balance after: 0 Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:02 UTC |
Hall Charles JGroup President
|
SaleCommon Stock | 3,000 | $250.94 | $752,820.00 |
DisclosureSEC source: 0001209191-21-049817 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,870 Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 19:26 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 2,900 | $249.43 | $723,351.93 |
DisclosureSEC source: 0001209191-21-049480 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,427 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.26 to $249.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 29, 2021 Filed Jul 29, 2021 18:32 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
SaleCommon Stock | 200 | $249.36 | $49,872.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · nonDerivative · entry 4 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,327 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.30 to $249.42, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 16 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2021 Trust Disclosed balance after: 20,000 Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 15 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,085.1606 F1 · balance_after: Includes 2,085.1606 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 3,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 14 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,085.1606 F1 · balance_after: Includes 2,085.1606 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 3,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 13 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 3,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 12 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,268 Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 3,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 11 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By DJP 2020 Trust Disclosed balance after: 52,979 Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 11,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 10 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,817.1606 F1 · balance_after: Includes 2,085.1606 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 11,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 9 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By JBP 2020 Trust Disclosed balance after: 46,098 Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 1,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 8 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,113.1606 F1 · balance_after: Includes 2,085.1606 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 1,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 7 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2011 GRAT Disclosed balance after: 0 Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 3,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 6 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,931.1606 F1 · balance_after: Includes 2,085.1606 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 28, 2021 Filed Aug 4, 2021 21:11 UTC |
Perlin Jonathan BPres-Clinical Operations & CMO
|
GiftCommon Stock | 3,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049818 · doc4.xml · nonDerivative · entry 5 Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Operations & CMO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2012 GRAT Disclosed balance after: 0 Read SEC document |
| July 28, 2021 Filed Nov 2, 2021 19:35 UTC |
RUTHERFORD BILL BCFO and EVP
|
GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-062528 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,457 Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:34 UTC |
Paslick P. MartinSVP and CIO
|
SaleCommon Stock | 7,466 | $250.00 | $1,866,500.00 |
DisclosureSEC source: 0001209191-21-048657 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,878 Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:33 UTC |
Hall Charles JGroup President
|
SaleCommon Stock | 3,000 | $249.94 | $749,820.00 |
DisclosureSEC source: 0001209191-21-048654 · doc4.xml · nonDerivative · entry 3 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,870 Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 5,500 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · derivative · entry 7 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 1,925 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · derivative · entry 6 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,925 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionStock Appreciation Right · Derivative | 1,375 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · derivative · entry 5 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,375 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Tax withholdingCommon Stock | 4,782 | $247.69 | $1,184,453.58 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · nonDerivative · entry 3 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,527 Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionCommon Stock | 5,500 | $68.96 | $379,280.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · nonDerivative · entry 2 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2021 Filed Jul 29, 2021 18:32 UTC |
Englebright Jane D.SVP and Chief Nursing Officer
|
Exercise / conversionCommon Stock | 3,300 | $47.97 | $158,301.00 |
DisclosureSEC source: 0001209191-21-048652 · doc4.xml · nonDerivative · entry 1 Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2021 Filed Jul 29, 2021 18:33 UTC |
Hall Charles JGroup President
|
GiftCommon Stock | 3,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048654 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,870 Read SEC document |
| July 22, 2021 Filed Jul 26, 2021 18:15 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
SaleCommon Stock | 886 | $246.90 | $218,751.81 |
DisclosureSEC source: 0001209191-21-048222 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,877 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.8683 to $246.94, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 19:19 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionStock Appreciation Right · Derivative | 17,080 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-21-048073 · doc4.xml · derivative · entry 5 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,080 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 19:19 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 9,614 | $249.25 | $2,396,289.50 |
DisclosureSEC source: 0001209191-21-048073 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,344 Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 19:19 UTC |
Paslick P. MartinSVP and CIO
|
Exercise / conversionCommon Stock | 17,080 | $69.58 | $1,188,426.40 |
DisclosureSEC source: 0001209191-21-048073 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2021 Filed Jul 23, 2021 19:10 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
SaleCommon Stock | 1,000 | $252.00 | $252,000.00 |
DisclosureSEC source: 0001209191-21-048069 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,899 Read SEC document |
| May 13, 2021 Filed Nov 12, 2021 17:27 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 4,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 6 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By LCF Trust (Reporting Person, Trustee) Disclosed balance after: 48,958 Read SEC document |
| May 13, 2021 Filed Nov 12, 2021 17:27 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 4,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 5 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| May 13, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 4,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 9 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By LM 2021 GRAT Disclosed balance after: 4,862 Read SEC document |
| May 13, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 4,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 8 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| May 13, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 4,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 7 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By JM 2021 GRAT Disclosed balance after: 4,863 Read SEC document |
| May 13, 2021 Filed Feb 14, 2022 18:31 UTC |
Morrow J WilliamFormer SVP - Fin. & Treasurer
|
GiftCommon Stock | 4,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009465 · doc5.xml · nonDerivative · entry 6 Morrow J William · CIK 0001696543 · Former SVP - Fin. & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,657.8464 F1 · balance_after: Includes 169.6229 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| May 12, 2021 Filed Nov 12, 2021 17:27 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 4,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 4 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 4,919 Read SEC document |
| May 12, 2021 Filed Nov 12, 2021 17:27 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 4,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 3 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 12, 2021 Filed Nov 12, 2021 17:27 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 4,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Indirect · By JMF Trust (Spouse and Robert Nagel, Co-Trustees) Disclosed balance after: 48,958 Read SEC document |
| May 12, 2021 Filed Nov 12, 2021 17:27 UTC |
Foster Jon MGroup President
|
GiftCommon Stock | 4,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064277 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,919 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.